NASDAQ:BCRX

BioCryst Pharmaceuticals Insider Trades

$15.37
-0.02 (-0.13 %)
(As of 09/23/2021 04:00 PM ET)
Add
Compare
Today's Range
$15.18
$15.46
50-Day Range
$14.21
$17.65
52-Week Range
$3.30
$18.48
Volume1.85 million shs
Average Volume4.60 million shs
Market Capitalization$2.75 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.59

BioCryst Pharmaceuticals (NASDAQ:BCRX) Insider Buying and Selling Activity

4.80% of BioCryst Pharmaceuticals' shares are owned by company executives, directors and other insiders. Over the past twelve months, BioCryst Pharmaceuticals insiders have sold shares 7 time(s), totalling $2,648,051.09. Insiders that have sold shares include George B Abercrombie, George B. Abercrombie, William P Sheridan, and Alane P Barnes.

Insider Buying and Selling by Quarter


BioCryst Pharmaceuticals (NASDAQ BCRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2021George B AbercrombieDirectorSell74,000$15.09$1,116,660.00  
7/15/2021George B. AbercrombieDirectorSell5,000$15.69$78,450.008,000  
5/27/2021William P SheridanInsiderSell71,759$15.00$1,076,385.0039,434  
5/24/2021George B AbercrombieDirectorSell6,667$13.90$92,671.309,667  
5/10/2021George B AbercrombieDirectorSell7,000$12.70$88,900.003,000  
12/11/2020Alane P BarnesVPSell13,741$7.96$109,378.36121,802  
12/4/2020Alane P BarnesVPSell13,741$6.23$85,606.43121,802  
8/11/2020Anthony DoyleCFOBuy54,000$4.08$220,320.0054,000  
11/18/2019Alane P BarnesVPBuy20,000$1.45$29,000.00102,061  
11/18/2019Jon P StonehouseCEOBuy50,000$1.45$72,500.00778,086  
11/18/2019Kenneth B Lee JrDirectorBuy5,000$1.45$7,250.0015,252  
11/18/2019Megan SniecinskiInsiderBuy45,000$1.45$65,250.0045,000  
5/22/2019Steve AselageDirectorBuy3,000$3.57$10,710.005,000  
5/17/2019Thomas R Staab IIInsiderSell9,750$7.65$74,587.50134,926  
5/15/2019Thomas R Staab IIInsiderSell11,750$7.81$91,767.50137,176  
5/13/2019Thomas R Staab IIInsiderSell19,500$7.70$150,150.00142,426  
5/9/2019Thomas R Staab IICFOSell9,750$7.63$74,392.50142,426  
5/6/2019Thomas R Staab IICFOSell9,000$7.75$69,750.00140,426  
5/2/2019Thomas R Staab IICFOSell7,750$7.30$56,575.00140,426  
4/4/2019Thomas R Staab IIInsiderSell7,500$8.81$66,075.00140,176  
3/12/2019Steve AselageDirectorBuy2,000$8.30$16,600.002,000  
1/28/2019Lynne PowellVPSell12,000$9.75$117,000.006,000  
1/28/2019Thomas R Staab IICFOSell5,000$9.85$49,250.00133,426  
1/25/2019Lynne PowellVPSell6,000$9.60$57,600.006,000  
1/18/2019Lynne PowellVPSell2,000$9.40$18,800.002,000  
1/16/2019Lynne PowellVPSell3,046$9.27$28,236.423,046  
1/14/2019Lynne PowellVPSell954$9.20$8,776.80954  
12/18/2018William P SheridanCMOSell20,488$7.58$155,299.042,725  
12/10/2018Lynne PowellVPSell4,000$9.06$36,240.002,000  
12/4/2018Thomas R Staab IIInsiderSell3,922$9.45$37,062.90  
11/30/2018Alane P BarnesVPSell44,290$9.07$401,710.30  
11/23/2018Thomas R Staab IIInsiderSell15,500$9.32$144,460.00142,383  
11/20/2018Lynne PowellVPSell15,470$8.55$132,268.508,798  
11/20/2018Thomas R Staab IIInsiderSell11,198$8.67$97,086.66137,458  
11/8/2018Lynne PowellVPSell5,280$8.15$43,032.008,905  
11/8/2018Thomas R Staab IIInsiderSell14,087$8.12$114,386.44138,055  
11/5/2018Lynne PowellVPSell100$8.00$800.008,705  
11/5/2018Thomas R Staab IIInsiderSell215$8.00$1,720.00137,598  
11/2/2018Thomas R Staab IICFOSell10,856$7.84$85,111.04144,739  
11/1/2018Lynne PowellVPSell1,544$7.51$11,595.448,605  
10/19/2018Lynne PowellVPSell100$7.50$750.0010,149  
10/19/2018Thomas R Staab IIInsiderSell3,150$7.45$23,467.50140,533  
10/3/2018Thomas R Staab IIInsiderSell9,850$7.24$71,314.00140,633  
8/9/2018William P SheridanCMOSell62,500$7.03$439,375.0085,713  
6/1/2018William P SheridanCMOSell42,112$6.30$265,305.6063,170  
11/13/2017William P SheridanCMOSell64,310$4.72$303,543.20  
9/18/2017Fred E CohenDirectorSell54,250$5.42$294,035.00173,660  
3/20/2017Thomas R Staab IICFOSell3,250$9.20$29,900.00144,710  
3/10/2017Thomas R Staab IIInsiderSell3,250$9.06$29,445.00120,563  
3/8/2017Thomas R Staab IIInsiderSell6,500$8.43$54,795.00123,813  
3/6/2017Thomas R Staab IIInsiderSell3,250$7.90$25,675.00120,563  
12/19/2016Thomas R Staab IIInsiderSell3,250$7.45$24,212.50127,437  
9/14/2016Alane P BarnesVPSell8,357$4.27$35,684.3979,377  
8/25/2016Yarlagadda S BabuVPSell30,000$4.06$121,800.00111,428  
8/16/2016Bros. Advisors Lp BakerMajor ShareholderSell4,046,590$5.00$20,232,950.00  
8/12/2016Thomas R Staab IIInsiderSell5,864$5.18$30,375.52128,745  
8/9/2016Thomas R Staab IIInsiderSell14,577$4.43$64,576.11130,051  
1/28/2016Bros. Advisors Lp Bakermajor shareholderBuy88,345$6.95$613,997.7523,459  
1/22/2016Bros. Advisors Lp Bakermajor shareholderBuy106,800$7.28$777,504.0023,459  
1/20/2016Bros. Advisors Lp Bakermajor shareholderBuy52,695$6.87$362,014.6523,459  
1/19/2016Bros. Advisors Lp Bakermajor shareholderBuy92,200$7.12$656,464.0023,459  
1/15/2016Bros. Advisors Lp Bakermajor shareholderBuy200,000$7.46$1,492,000.0023,459  
12/21/2015Thomas R Staab IICFOSell3,052$10.86$33,144.72136,592  
12/17/2015Thomas R Staab IICFOSell3,000$10.49$31,470.00139,644  
7/20/2015Thomas R Staab IICFOSell3,500$16.50$57,750.00  
6/22/2015Thomas R Staab IICFOSell3,750$16.00$60,000.00  
6/19/2015Alane P BarnesVPSell3,000$15.00$45,000.00  
6/19/2015Jon P StonehouseCEOSell20,000$15.02$300,400.00  
6/19/2015Thomas R Staab IICFOSell16,375$14.36$235,145.00  
6/19/2015William P SheridanCMOSell70,389$15.05$1,059,354.45  
6/5/2015Thomas R Staab IICFOSell6,000$12.75$76,500.00  
5/18/2015Thomas R Staab IICFOSell3,000$11.00$33,000.00  
3/19/2015Yarlagadda S BabuVPSell12,105$10.16$122,986.80  
3/5/2015Yarlagadda S BabuVPSell37,400$10.59$396,066.00  
3/4/2015Yarlagadda S BabuVPSell10,495$10.50$110,197.50  
2/20/2015Nancy J HutsonDirectorBuy10,000$10.27$102,700.00  
12/30/2014William P SheridanCMOSell128,399$12.36$1,587,011.64  
12/29/2014Thomas R Staab IICFOSell9,500$12.56$119,320.00  
12/29/2014William P SheridanCMOSell105,295$12.43$1,308,816.85  
8/27/2014Thomas R Staab IICFOSell10,000$13.58$135,800.00  
7/1/2014Thomas R Staab IICFOSell3,125$13.00$40,625.00  
6/23/2014Thomas R Staab IICFOSell3,125$12.49$39,031.25  
6/17/2014Thomas R Staab IICFOSell3,125$12.00$37,500.00  
3/14/2014Thomas Staab IICFOSell3,125$11.24$35,125.00126,616  
3/6/2014Kenneth Lee, Jr.DirectorSell12,665$12.69$160,718.8510,252  
11/12/2013George AbercrombieDirectorBuy3,000$6.19$18,570.006,000  
8/1/2013Felix BakerMajor ShareholderBuy1,136,364$4.40$5,000,001.60  
3/5/2013George B AbercrombieDirectorBuy3,000$1.23$3,690.00  
12/14/2012Peder JensenDirectorBuy20,000$1.51$30,200.00  
(Data available from 1/1/2013 forward)
speech bubbles
speech bubbles











BioCryst Pharmaceuticals (NASDAQ:BCRX) Insider Trade Frequently Asked Questions

Who is on BioCryst Pharmaceuticals's Insider Roster?

The list of insiders at BioCryst Pharmaceuticals includes Alane P Barnes, Anthony Doyle, George B Abercrombie, Jon P Stonehouse, Kenneth B Lee Jr, Lynne Powell, Megan Sniecinski, Steve Aselage, Thomas R Staab II, and William P Sheridan.Learn more on BCRX's insiders

What percentage of BioCryst Pharmaceuticals stock is owned by insiders?

4.80% of BioCryst Pharmaceuticals stock is owned by insiders. Learn more on BCRX's insider holdings

Which BioCryst Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased BioCryst Pharmaceuticals stock in the last 24 months: Alane P Barnes ($29,000.00), Anthony Doyle ($220,320.00), Jon P Stonehouse ($72,500.00), Kenneth B Lee Jr ($7,250.00), and Megan Sniecinski ($65,250.00).

How much insider buying is happening at BioCryst Pharmaceuticals?

Insiders have purchased a total of 174,000 BioCryst Pharmaceuticals shares in the last 24 months for a total of $394,320.00 bought.

Which BioCryst Pharmaceuticals insiders have been selling company stock?

The following insiders have sold BioCryst Pharmaceuticals stock in the last 24 months: Alane P Barnes ($194,984.79), George B Abercrombie ($1,298,231.30), and William P Sheridan ($1,076,385.00).

How much insider selling is happening at BioCryst Pharmaceuticals?

Insiders have sold a total of 191,908 BioCryst Pharmaceuticals shares in the last 24 months for a total of $2,648,051.09 sold.

This page was last updated on 9/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.